On February 4, the pharmaceutical group was charged with “serious fraud” and “intentional damage.” The Sanofi group is under investment
On February 4, the pharmaceutical group was charged with “serious fraud” and “intentional damage.”
The Sanofi group is being investigated for “involuntary manslaughter” in an investigation into the marketing of the antiepileptic drug Depakine opened in 2016, which confirms information from the newspaper Le Monde, the company announced Monday. Last February, the pharmaceutical company was already accused of “aggravated tort of fraud” and “intentional damage.”
The investigation, opened in September 2016, aimed to determine whether there was deception “about the risks associated with the use of the product and the precautions that must be taken so that its use is dangerous to human health”, and covered the period of 1990 to April 2015.
The group contested the accusation.
The molecule in question, sodium valproate, has been marketed since 1967 under the Sanofi brand Depakine, but also under generic brands, and is prescribed to people with bipolar disorder. It poses a high risk of birth defects to the fetus if taken by a pregnant woman. The number of children disabled by sodium valproate, the molecule found in Depakine and used against epilepsy and bipolar disorder, is estimated to be between 15 and 30,000, according to studies.
Summer offer: Take advantage of the special offer of 2 months for €1 I subscribe
ALSO READ >> Sanofi: toxic waste, but “since when?”
The group claims that it “has complied with its disclosure obligations and questions the adequacy of these procedures.” “The laboratory entered the investigation room to challenge his accusation. All these elements do not affect the responsibility of the laboratory”, he says before.
Read our full file
Sanofi
Sanofi assures that France is “at the center” of its strategy, Sanofi wants to eliminate a thousand jobs in France, the plan is “shameful” for the unions Covid-19 vaccine: Sanofi would not be part of the 5 candidates chosen by Adut
In July of last year, the Judiciary recognized for the first time the responsibility of the State, as well as Sanofi and doctors, for the devastating effects of the antiepileptic Depakine, ordering it to compensate the families of severely disabled children.
Date updated: August 3, 2020, 20:58
Categories: Optical Illusion
Source: newstars.edu.vn